questionsmedicales.fr
Glucides
Oses phosphates
Inositol phosphates
Inositol phosphates : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cancer-Associated Fibroblasts
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inositol phosphates : Questions médicales les plus fréquentes",
"headline": "Inositol phosphates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inositol phosphates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-23",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inositol phosphates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oses phosphates",
"url": "https://questionsmedicales.fr/mesh/D013403",
"about": {
"@type": "MedicalCondition",
"name": "Oses phosphates",
"code": {
"@type": "MedicalCode",
"code": "D013403",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inositol 1,4,5-trisphosphate",
"alternateName": "Inositol 1,4,5-Trisphosphate",
"url": "https://questionsmedicales.fr/mesh/D015544",
"about": {
"@type": "MedicalCondition",
"name": "Inositol 1,4,5-trisphosphate",
"code": {
"@type": "MedicalCode",
"code": "D015544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.894.480.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide phytique",
"alternateName": "Phytic Acid",
"url": "https://questionsmedicales.fr/mesh/D010833",
"about": {
"@type": "MedicalCondition",
"name": "Acide phytique",
"code": {
"@type": "MedicalCode",
"code": "D010833",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.894.480.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Inositol phosphates",
"alternateName": "Inositol Phosphates",
"code": {
"@type": "MedicalCode",
"code": "D007295",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Adolfo Saiardi",
"url": "https://questionsmedicales.fr/author/Adolfo%20Saiardi",
"affiliation": {
"@type": "Organization",
"name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK. Electronic address: a.saiardi@ucl.ac.uk."
}
},
{
"@type": "Person",
"name": "Henning J Jessen",
"url": "https://questionsmedicales.fr/author/Henning%20J%20Jessen",
"affiliation": {
"@type": "Organization",
"name": "Institute of Organic Chemistry & CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Gabriel Schaaf",
"url": "https://questionsmedicales.fr/author/Gabriel%20Schaaf",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Nutrition, Institute of Crop Science and Resource Conservation, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany. gabriel.schaaf@uni-bonn.de."
}
},
{
"@type": "Person",
"name": "Debabrata Laha",
"url": "https://questionsmedicales.fr/author/Debabrata%20Laha",
"affiliation": {
"@type": "Organization",
"name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen B Shears",
"url": "https://questionsmedicales.fr/author/Stephen%20B%20Shears",
"affiliation": {
"@type": "Organization",
"name": "Inositol Signaling Section, NIEHS, 111, Alexander Drive, Research Triangle Park, Durham, NC 27709, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy.",
"datePublished": "2023-03-23",
"url": "https://questionsmedicales.fr/article/36965647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.critrevonc.2023.103967"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.",
"datePublished": "2022-12-17",
"url": "https://questionsmedicales.fr/article/36538999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cellsig.2022.110567"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37418988",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2023.110601"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts: from basic science to anticancer therapy.",
"datePublished": "2023-07-03",
"url": "https://questionsmedicales.fr/article/37394578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s12276-023-01013-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998825",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addr.2022.114504"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Oses phosphates",
"item": "https://questionsmedicales.fr/mesh/D013403"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inositol phosphates",
"item": "https://questionsmedicales.fr/mesh/D007295"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inositol phosphates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inositol phosphates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inositol phosphates",
"description": "Comment diagnostiquer un déséquilibre en inositol phosphates ?\nQuels tests sont utilisés pour évaluer les inositol phosphates ?\nLes inositol phosphates sont-ils mesurables dans les tissus ?\nY a-t-il des marqueurs spécifiques pour les inositol phosphates ?\nLes tests génétiques sont-ils utiles pour les inositol phosphates ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inositol phosphates",
"description": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?\nLes inositol phosphates affectent-ils la santé mentale ?\nY a-t-il des signes physiques d'un déséquilibre ?\nLes inositol phosphates influencent-ils le métabolisme ?\nPeut-on observer des symptômes neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inositol phosphates",
"description": "Comment prévenir les déséquilibres en inositol phosphates ?\nLes suppléments sont-ils nécessaires pour la prévention ?\nY a-t-il des habitudes de vie à adopter ?\nLes consultations médicales sont-elles importantes ?\nLes facteurs environnementaux influencent-ils les niveaux ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inositol phosphates",
"description": "Quels traitements existent pour les déséquilibres en inositol phosphates ?\nLes médicaments peuvent-ils aider avec les inositol phosphates ?\nY a-t-il des thérapies alternatives pour les inositol phosphates ?\nComment les changements alimentaires aident-ils ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inositol phosphates",
"description": "Quelles complications peuvent survenir avec des déséquilibres ?\nLes inositol phosphates sont-ils liés à des maladies chroniques ?\nY a-t-il des risques pour la santé reproductive ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications psychologiques sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inositol phosphates",
"description": "Quels sont les facteurs de risque pour les déséquilibres ?\nL'âge influence-t-il les niveaux d'inositol phosphates ?\nLes maladies métaboliques sont-elles un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un déséquilibre en inositol phosphates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux d'inositol phosphates dans le corps."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les inositol phosphates ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests biochimiques et les analyses de métabolites urinaires sont courants."
}
},
{
"@type": "Question",
"name": "Les inositol phosphates sont-ils mesurables dans les tissus ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être effectuées pour évaluer les niveaux dans les tissus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour les inositol phosphates ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme l'IP3 peuvent indiquer des déséquilibres dans la signalisation cellulaire."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les inositol phosphates ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à identifier des troubles métaboliques liés aux inositol phosphates."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de l'humeur et problèmes métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les inositol phosphates affectent-ils la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent être liés à des troubles de l'humeur comme la dépression."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes physiques d'un déséquilibre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles de la peau ou des problèmes digestifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les inositol phosphates influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle dans la régulation du métabolisme lipidique et glucidique."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et de la mémoire peuvent être liés à des déséquilibres."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres en inositol phosphates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires pour la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments peuvent être bénéfiques, surtout en cas de carence alimentaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à adopter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier et la gestion du stress peuvent aider à maintenir l'équilibre."
}
},
{
"@type": "Question",
"name": "Les consultations médicales sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter des déséquilibres précocement."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les niveaux ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut affecter le métabolisme des inositol phosphates."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déséquilibres en inositol phosphates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments d'inositol et des modifications alimentaires peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider avec les inositol phosphates ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments psychotropes peuvent influencer les niveaux d'inositol phosphates."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives pour les inositol phosphates ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme la phytothérapie peuvent être explorées, mais nécessitent des études."
}
},
{
"@type": "Question",
"name": "Comment les changements alimentaires aident-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits et légumes peut améliorer les niveaux d'inositol."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés selon les besoins individuels et les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des déséquilibres ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, neurologiques et psychologiques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les inositol phosphates sont-ils liés à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent être associés à des maladies comme le diabète."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé reproductive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent affecter la fertilité et la santé reproductive."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en cas de déséquilibre prolongé."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines peuvent être réversibles avec un traitement approprié et un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déséquilibres ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation pauvre, le stress et des antécédents familiaux peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux d'inositol phosphates ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux peuvent diminuer avec l'âge, augmentant le risque de déséquilibre."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme le diabète peuvent affecter le métabolisme des inositol phosphates."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie inactif peut contribuer à des déséquilibres en inositol phosphates."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut perturber le métabolisme des inositol phosphates."
}
}
]
}
]
}
Cancer-associated fibroblasts (CAFs) are the prominent stromal cell population in the tumor microenvironment (TME), which play an indispensable role in cancer progression and response to therapy. CAFs...
Current cancer therapeutic strategies are generally not sufficient to eradicate malignancy, as cancer stroma cells contribute to tumor evasion and therapeutic resistance. Cancer-associated fibroblasts...
The tumour microenvironment (TME) is critical for the initiation, progression, and metastasis of tumours, and cancer-associated fibroblasts (CAFs) are the most dominant cells and have attracted intere...
Cancer-associated fibroblasts (CAFs), as a central component of the tumor microenvironment in primary and metastatic tumors, profoundly influence the behavior of cancer cells and are involved in cance...
The tumor microenvironment (TME) is emerging as one of the primary barriers in cancer therapy. Cancer-associated fibroblasts (CAF) are a common inhabitant of the TME in several tumor types and play a ...
Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment that mediate resistance of cancer cells to anticancer drugs. Tranilast is an antiallergic drug that suppresses ...
In recent decades, many reports have been published on the composition and function of the tumor microenvironment (TME), among which cancer-associated fibroblasts (CAFs) have received much attention. ...
Fibroblasts turn into cancer associated fibroblasts (CAFs) in the tumor microenvironment, which play an important role in tumor progression. However, the mechanism is unclear....
To investigate the role of CAFs with HS6ST1-overexpression in cell migration and invasion effects....
Human primary CAFs were isolated and identified from intrahepatic cholangiocarcinoma. mRNA profiles differences between CAFs and NFs were examined by using transcriptome sequencing. Using Transwell® m...
Successfully isolated CAFs is positive staining with αSMA, FSP-1, FAP, and PDGFR-β. Transcriptome sequencing showed that differently expressed genes were enriched in the function of the extracellular ...
HS6ST1 is new possibilities for targeting the CAFs to reduce cholangiocarcinoma growth and metastasis....
Cancer‑associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the mali...
Liver metastasis (LM) is a leading cause of cancer-related deaths in CRC patients, whereas the associated mechanisms have not yet been fully elucidated. Therefore, it is urgently needed to deeply expl...
The bulk RNA sequencing data and clinicopathological information of CRC patients were enrolled from the TCGA and GEO databases. The single-cell RNA sequencing (scRNA-seq) datasets of CRC were collecte...
In the present study, hundreds of differentially expressed genes (DEGs) were selected in LM-CRC compared to primary CRC, and these DEGs were significantly associated with the regulation of endopeptida...
Our study selected four characteristic genes of LM-CRC and identified ANGPTL2...